Defunct Company
Total Trials
10
As Lead Sponsor
0
As Collaborator
Total Enrollment
6,601
NCT00666835
Study to Evaluate the Efficacy and Safety of HX575 Hexal AG vs ERYPO® for the Treatment of Anemia in Hemodialysis Patients
Phase: Phase 3
Role: Collaborator
Start: Apr 30, 2004
Completion: Jan 31, 2006
NCT00711958
Study to Assess the Efficacy and Safety of HX575 in the Treatment of Chemotherapy Associated Anemia in Cancer Patients
Start: Nov 30, 2004
Completion: Dec 31, 2005
NCT00632125
Post-authorization Safety Study in CKD Subjects Receiving HX575 i.v.
Phase: Phase 4
Start: Jul 31, 2008
Completion: Sep 30, 2010
NCT01121237
MONITOR-CKD5 - Multi-level Evaluation of Anaemia Treatment, Outcomes, and Determinants in Chronic Kidney Disease Stage 5
Phase: N/A
Start: Feb 28, 2010
Completion: Nov 30, 2014
NCT01766934
Non-interventional, Long-term Safety Data Collection of Zarzio® / Filgrastim HEXAL® in Stem Cell Donors
Start: May 31, 2011
Completion: Aug 29, 2024
NCT01891864
Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Etanercept (GP2015) and Enbrel
Start: Jun 30, 2013
Completion: Mar 31, 2015
NCT02016105
Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Adalimumab (GP2017) and Humira
Start: Dec 31, 2013
Completion: Feb 29, 2016
NCT02514772
GP2013 Treatment in Patients With Active Rheumatoid Arthritis, Previously Treated With Rituxan® or MabThera®
Start: Jul 31, 2015
Completion: Oct 31, 2016
NCT02744755
Clinical Trial to Compare Treatment With GP2017 and Humira® in Patients With Rheumatoid Arthritis
Start: Mar 31, 2016
Completion: Sep 26, 2017
NCT03974100
Study Investigating PK, PD, Efficacy, Safety, and Immunogenicity of Biosimilar Denosumab (GP2411) in Patients With Postmenopausal Osteoporosis
Start: Jul 2, 2019
Completion: Apr 22, 2022